SEC Form 10-K filed by Strata Critical Medical Inc.
$SRTA
Transportation Services
Consumer Discretionary
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/25/2026 | $8.00 | Buy | Craig Hallum |
| 3/25/2026 | $8.00 | Buy | B. Riley Securities |
| 12/2/2025 | $8.00 | Buy | Lake Street |
Craig Hallum initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
B. Riley Securities initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
Lake Street resumed coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the second quarter ended July 31, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be prov
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customersAdds significant scale to Transplant Clinical, Strata’s fastest growing business line, with a similar, rapid growth trajectory$21.5 million acquisition completed at mid-single-digit multiple of Adjusted EBITDA, pre-synergy, consistent with Strata’s capital deployment strategy NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program ("HLT-NRP"), a provider of transplant surgical recovery services in the United
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. "The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States," said Lou Verdetto, CEO of Strata's Clinical Division. "More than just unlocking the ability to win new perfusion contracts in the region, LPS also expands the national footpr
4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
SCHEDULE 13G/A - Strata Critical Medical, Inc. (0001779128) (Subject)
SCHEDULE 13G - Strata Critical Medical, Inc. (0001779128) (Subject)
8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the second quarter ended July 31, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be prov
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. "The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States," said Lou Verdetto, CEO of Strata's Clinical Division. "More than just unlocking the ability to win new perfusion contracts in the region, LPS also expands the national footpr
Revenue increased 87.4% year-over-year to $67.4 million in Q1 2026Logistics revenue and gross profit grew 32.4% and 29.9% year-over-year, respectively, in Q1 2026, which represents Strata's organic growthClinical revenue and gross profit sequential growth of 12.7% and 29.2%, respectively in Q1 2026 versus Q4 2025 Q1 2026 net income from continuing operations of $2.4 millionAdjusted EBITDA(1) of $6.4 million in Q1 2026Completed bolt-on acquisition of Ohio Valley Perfusion AssociatesReiterating full year 2026 guidance NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financial results for the first quar
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customersAdds significant scale to Transplant Clinical, Strata’s fastest growing business line, with a similar, rapid growth trajectory$21.5 million acquisition completed at mid-single-digit multiple of Adjusted EBITDA, pre-synergy, consistent with Strata’s capital deployment strategy NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program ("HLT-NRP"), a provider of transplant surgical recovery services in the United
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of Strata Critical Medical, Inc. ("Strata" or the "Company"), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees. Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health care system headquartered in Vail, Colorado. "We are very excited to welcome Will Cook to our board of directors," said Melissa Tomkiel, Strata's Co-Chief Executive Office